Harrow Health Inc (HROW) Stock Forecast & Price Target
Harrow Health Inc · NASDAQ
$37.47-0.98 (-2.55%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Harrow Health Inc, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $63.00 to $88.00, so the covering firms are broadly aligned. The average target of $75.50 sits 101% above the current $37.47. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.38 next quarter toward $2.68 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Harrow Health Inc.
As of Jul, 7 of 7 firms rate HROW a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
HROW EPS & revenue forecast
EPS · NEXT QUARTER
$0.38
Range $0.24 – $0.48 · 3 analysts · +14% YoY
Next period, 3 analysts expect Harrow Health Inc to earn $0.38 a share (range $0.24 – $0.48), versus $0.33 a year earlier. Full-year consensus is $0.45, growing to $2.68 the year after.
REVENUE · NEXT QUARTER
$101.7M
Range $97.2M – $108.3M · 3 analysts · +42% YoY
Revenue is expected to reach $101.7M (range $97.2M – $108.3M), +42.0% year-over-year. Full-year consensus is $348.5M, rising to $517.5M next year.
Top analysts covering Harrow Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HROW.
#1
Mayank Mamtani
B. Riley Securities · Rank #9
Buy
$60.00+60.1% to target
Overall win rate
53%
+ Follow
#2
Chase Knickerbocker
Craig-Hallum · Rank #25
Buy
No targeton HROW
Overall win rate
58%
+ Follow
#3
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$70.00+86.8% to target
Overall win rate
34%
+ Follow
#4
Thomas Shrader
BTIG
Buy
$63.00+68.1% to target
Coverage
—
+ Follow
#5
TF
Thomas Flaten
Lake Street
Buy
$60.00+60.1% to target
Coverage
—
+ Follow
HROW stock forecast FAQ
What is HROW's average 12-month price target?+
The 2 analysts with a live target average $75.50 for Harrow Health Inc over the next 12 months, ranging from a $88.00 high to a $63.00 low.
Is HROW stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for HROW?+
The Street-high target is $88.00 (Cantor Fitzgerald), and the Street-low is $63.00 (BTIG). The average of all 2 active targets is $75.50.
How many Wall Street analysts cover HROW?+
7 analysts have an active rating on Harrow Health Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering HROW?+
Among analysts who currently cover HROW, Mayank Mamtani of B. Riley Securities has the strongest overall Quantellect track record (Rank #9). Their current call is Buy with a $60.00 target.
What is Harrow Health Inc's projected EPS for next quarter?+
The consensus estimate is $0.38 per share (range $0.24 – $0.48) across 3 analysts. Full-year EPS is projected at $0.45, rising to $2.68 the following year.
How much revenue is Harrow Health Inc expected to report next quarter?+
Consensus revenue is $101.7M (range $97.2M – $108.3M). Full-year revenue is projected at $348.5M, growing to $517.5M next year.
Have analysts been upgrading or downgrading HROW lately?+
As of Jul, 7 of 7 firms rate HROW a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HROW calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
